Abstract: Objective: To investigate the risk factors of liver function damage induced by microwave ablation (MWA) in patients with hepatocellular carcinoma (HCC). Methods: We retrospectively reviewed the liver function of 498 patients with HCC undergoing MWA treatment. The dynamic changes of liver enzymes and Child-Pugh scores were observed. The potential risk factors, including the relative position between the tumor and portal vein (PV), tumor numbers, ablation volumes, Child-Pugh classifications, platelet, APRI and MELD scores, were analyzed. Results: 13.86% (69/498) patients suffered from liver function damage, that is, having an increase of two in Child-Pugh score three days after MWA. The incidences of liver dysfunction of the patients with tumors close to PV, more than three tumors, ablation volumes larger than or equal to 22.5 cm 3 , Child-Pugh classification B, APRI > 1.6, MELD > 30 or PLT < 110 × 10 9 /L were 53.85%, 46.15%, 20.60%, 24.24%, 31.53%, 22.55% or 18.92%, respectively, all of which are much higher than those of patients without the aformentioned characteristics. Conclusions: MWA can cause a transient deterioration of liver function. Patients with tumors close to PV, large number of tumors or large ablation volumes may present a great fluctuation of liver enzymes and an aggravation of liver dysfunction. In addition, poor liver reserve function is a risk factor of liver function damage, but not the elevation of liver enzymes after MWA.
Introduction
Hepatocellular carcinoma (HCC) is one of the most common malignancy around the world [1] . Approximately, up to one million new liver cancer cases are diagnosed and about 745,500 people die of HCC-related diseases each year, making it already the second commonest cause of cancer-related mortality [2] .
Thermal ablation techniques, especially percutaneous radiofrequency ablation (RFA) and microwave ablation (MWA), are widely used in the treatment of HCC in recent years [3] [4] [5] [6] [7] because of their minimal invasion and superior treatment efficacy. However, ablation of tumors usually accompanies with the deterioration of liver function [8, 9] . Previous studies showed that liver function damage after RFA is related to the location of tumors, level of platelet and Child-Pugh score [8, 10, 11] . Compared with RFA, MWA have a higher output power and larger ablation volume and therefore may increase the possibility of liver dysfunction [12, 13] . The dynamic changes of liver function induced by MWA in patients with HCC, however, have not been well studied. In China, however, most of the patients are with poor liver reserve function due to the chronic viral hepatitis and liver cirrhosis [1, 2] . These patients, hence, are prone to suffer from liver dysfunction after thermal ablation. To prevent from the possible liver dysfunction and further complications, it is of paramount importance to understand their related factors.
In the present study we monitored the changes of liver function after MWA. A total of seven fac-tors, including the relative position between the tumor and PV, tumor numbers, ablation volumes, Child-Pugh classification, PLT, APRI and MELD scores, were included in this study to explore the reasons of the occurrence of liver dysfunction.
Methods

Patients
This retrospective study was approved by Tianjin Third Central Hospital Institutional Review Board. All procedures performed in this study involving human participants were in accordance with the ethical standards of the
MWA ablation
MTC-3 microwave therapy instrument (Forsea Microwave & Electronic Research Institute, Nanjing, China) with a frequency of 2450 MHz and an output power of 40-80 W was used for MWA therapy. The diameter of the cooling unipolar needle was 16-guage and the length of it is 15 cm. All of the MWA procedures were performed percutaneously by using the ultrasound systems of Philips IU-22 (Philips, Bothell, WA, USA) with a frequency of 1-5 MHz convex array probe under the real-time US guidance. In order to achieve complete necrosis of a tumor, the radius of ablation volume was 0.5 cm larger than that of the tumor. /L or the international normalized ratio was ≤ 1.7; (7) did not receive any other invasive treatment, such as PEI, TACE, RFA, during preoperative and postoperative period and (8) they did not suffer from non-liver related serious complications after MWA. Patients were excluded from the study for the following reasons: (1) with a tumor > 5 cm in size or with > 5 tumors; (2) undergoing other invasive treatment during preoperative or postoperative period; (3) with serious complications which may have an effect on liver function damage. A total of 498 patients were included in this study ( Table 1 ). All of the diagnoses were reconfirmed by ultrasound guided percutaneous biopsy. Int J Clin Exp Med 2018;11(10):10458-10467
Follow-up
To confirm the curative effect of MWA, enhanced computed tomogram (CT) or magnetic resonance imaging (MRI) scan was performed one month after MWA. Complete tumor ablation was confirmed when the postoperative hypoattenuation/hypointensities was in all the phases of the CECT or CEMRI. Blood tests for liver function, complete blood count and prothrombin time (PT) were routinely performed along with imaging.
Assessment of liver function and data collection
The size of tumors, number of tumors, relative position between the tumor and portal vein (PV), blood platelet count, serum albumin (ALB), alanine transaminase (ALT), aspartate aminotransferase (AST), alkalinephosphatase (ALP), gamma-glutamyltranspeptidase (γ-GGT), serum total bilirubin (TBIL), Child-Pugh classification, MELD score, total ablation volume and aspartate aminotransferase-to-platelet ratio index (APRI) were collected. The laboratory test was performed and Child-pugh scores were collected before, 3 days after and 1 month after MWA. Based on the relative position between the tumor and PV, the tumors of the patients were divided into four groups, (1) far away from PV; (2) close to the third branch of PV (< 5 mm); (3) close to the second branch of PV (< 5 mm); (4) close to the first branch of PV (< 5 mm). If a tumor was near by the furcation of portal vein, the tumor was classified to the group with the larger branch. Deterioration of liver function was defined as an increase of Child-Pugh score by two three days after MWA therapy.
Statistics
Continuous variables are shown as mean ± standard error. Categorical variables are presented by frequencies and percentages. Comparisons between liver function parameters at different times were performed using the repeated measures analysis of variance or paired Student's t-test. The Receiver Operating Characteristic Curve (ROC) was used to determine the cut-of value. A p-value of less than 0.05 indicated a significant difference. All the statistical analysis was conducted using SPSS package.
Results
All the patients were successfully treated by percutaneous microwave ablation without any procedure-related death. 721 tumors were included in this study. Among them, 156 tumors were close to the PV and the rest 565 tumors were far away from PV. Complete response was achieved in 409 (98.08%) of 417 patients with tumors far away from the PV and in 89 (95.70%) of 93 patients with tumors close to a branch of the PV (Figure 1 ), respectively.
Three days after MWA, 91 patients with a classification of Child-Pugh A shifted to B, 12 pa- tients from B to C and one patient from A to C. A total of 69 patients suffer from liver dysfunction, that is, have an increase of two in ChildPugh score three days after MWA.
The changes of liver function indicators were shown in Table 2 . Large fluctuations in levels of ALB, ALT, AST and TBIL were observed three days after treatment, while the concentrations of ALP and γ-GGT were relative stable.
Effects of the relative position between the tumor and PV on liver function
The incidences of liver dysfunction of the patients with tumors far away from PV, close to the third branch, the second branch and the first branch of PV were 9.58% (39/407), 29.17% (21/72), 53.85% (7/13) and 33.33% (2/6), respectively (P < 0.001). The time evolutions Figure 3 . Three days after MWA, the levels of ALT increased by 131.01 ± 148.45, 204.03 ± 2210.79 U/L and 521.00 ± 513.08 U/L respectively in patients with one, two or three and more than three tumor(s) (P < 0.001). The levels of AST increased by 153.46 ± 171.48, 225.96 ± 193.25, 548.40 ± 487.81 U/L, respectively (P < 0.001) and of TBIL, 6.31 ± 11.98, 9.04 ± 11.50 and 20.37 ± 19.60 (μmol/L), respectively (P < 0.001). The changes of the concentrations of ALB of the three groups had no statistically significance.
Effects of the ablation volumes on liver function
ROC curve was adopted to find out the cut-off value of ablation volumes, i.e. 22.5 cm 3 . In this study, 265 patients had ablation volumes less than 22.5 cm 3 and 233 patients were with Figure 2 . Effects of the relative position between the tumor and PV on the dynamic changes of liver biochemical laboratory values three days after and one month after MWA.
of liver biochemical laboratory values, including ALB, ALT, AST and TBIL were shown in Figure 2 . 
Effects of the tumor numbers on liver function
The patients with more than three tumors had an incidence of 46.15% for liver dysfunction, higher than those with two or three tumors (20.81%) and with only a tumor (9.52%). Time evolutions of liver biochemical laboratory values were shown in Int J Clin Exp Med 2018;11(10):10458-10467 ablation volumes lager than or equal to 22.5 cm 3 . Liver dysfunction incidences in patients with small and large ablation volumes were 7.92% and 20.60%, respectively, (P < 0.001). The time evolutions of liver biochemical laboratory values for two groups were shown in Figure  4 . The differences between the two groups in the elevated levels of ALT, AST and TBIL were statistically significant (< 22. 
Effects of APRI on liver function
Patients were divided into three groups according to the cut-off values of APRI, namely, ≤ 0.8, 
Effects of the Child-Pugh classification before MWA on liver function
The incidence of patients with Child-Pugh classification B suffering from liver dysfunction was 24.24% (16 of 66), much higher than that of patients with classification A (53 of 432, 12.17%, P=0.009). The time evolutions of liver biochemical laboratory values for the two groups were shown in Figure 5 . Three days after MWA, the levels of ALB decreased from 41.18 ± 4.78 to 37.17 ± 4.24 g/L in patients with Child-Pugh classification A and from 31.64 ± 4.84 to 31.40 ± 3.82 g/L in patients with classification B. The decreased levels of ALB in the classification A group was greater than B group (3.99 ± 4.56 vs 0.46 ± 4.77 g/L, P < 0.001). The increased level of ALT was 175.23 ± 203.66 U/L three days after MWA in the classification A group, also greater than that in the classification B group (83.23 ± 125.08 U/L), P < 0.001. The elevated concentrations of 0.8 to 1.6 and > 1.6. The numbers of patients in the three groups were 241, 146 and 111, respectively. The possibilities of liver dysfunction were related to the APRI and the corresponding liver dysfunction rates for the three groups were 6.44%, 12.33% and 31.53%, respectively (P < 0.001). The changes of the liver biochemical laboratory values of the thThe patients were classified into three groups according to the cut-off values of MELD score, namely, MELD score < 25, 25 ≤ MELD score < 30, and MELD score ≥ 30. The numbers of the patients of the three groups were 139, 257 and 102, respectively. The corresponding incidences of liver dysfunction were 5.76%, 14.79% and 22.55% (p < 0.001), respectively. The incidence ree groups before and after MWA treatment were shown in Figure 6 . All the fluctuations in ALB, AST and TBIL, except in ALT, had no statistically significance. The smaller the APRI is, the more the concentration of ALT increases, i.e., 199.10 ± 225.55 U/L when APRI ≤ 0.8, 150.29 ± 169.68 U/L when APRI between 0.8 to 1.6, and 101.50 ± 142.62U/L when APRI > 1.6.
Effects of PLT on liver function
According to the ROC curve, the cut-off of PLT was found to be 110 × 10 
Effects of MELD scores on liver function
of liver dysfunction of patients with MELD scores ≥ 30 was about 4 times of that of patients with MELD scores < 25. The time evolutions of the liver biochemical laboratory values for the three groups were shown in Figure 8 . All the changes of liver biochemical laboratory values before and after MWA among the above-mentioned three groups were not statistically significant (ALB, P=0.242; ALT, patient shifted from B to C. CT scan showed a large volume ascites. Branched chain amino acid (BCAA) and ornithine aspartate were used to reduce the blood ammonia. Drainage of ascites was admitted. Liver protecting and prophylactic antibiotics therapy were performed. Two weeks later, the physical condition of the patient was improved with the symptoms of hepatic coma and ascites disappeared. The 
Case report
This patient was a 72-year-old woman with hepatitis C virus related liver cirrhosis. She was admitted to our institution for the treatment of three recurrences HCC tumors with diameters of 2.6, 2.3 and 1.5 cm, one of which closed to the third branch of PV. The patient was treated by the TACE and MWA therapy for HCC several months ago. The laboratory data showed that the levels of PLT, ALB, ALT, AST, ALP, γ-GGT and TBIL of the patients were 69 (10 
Discussion
Nowadays, the demand for security of thermal ablation is getting higher and higher. The corresponding risk factors of some of complications, therefore, were clarified in previous studies [14] [15] [16] . However, due to the relatively low incidence of serious liver dysfunction, the potential thermal damage of liver function mentioned in previous studies [8, 11, 17] , is usually ignored in practice. The aim of this study was to investigate effects of MWA on liver function and the risk factors of liver function damage.
Our results show that the concentration of ALT, AST and TBIL increased while the level of ALB decreased three days after treatment, all of which recovered within one month except for TBIL. 13.86% (69/498) patients suffered from liver function damage. The incidence of liver dysfunction in this study is lower than that in the studies of Koda et al. and Li et al. [17, 18] , in which the incidences were 25% and 36%, respectively. The low incidence of liver function damage in our study may be on account of good liver reserve functions of the patients. Moreover, we investigated the risk factors of liver function damage systematically.
The results of our study demonstrate that the tumor-related local factors have effects on liver enzymes and reserve function. Patients with tumor(s) close to PV, large number of tumors or large ablation volume have significant fluctuations in liver enzymes and are prone to suffer from liver function damage. We suggest that there are two reasons resulting in the aggravating liver function damage from above three factors. Firstly, the heat produced by MWA may cause injury of the normal hepatic parenchyma surrounding the tumor. With the increase in tumor numbers or ablation volume, more parenchyma is ablated and more serious liver damage may happen. Our conclusion is consistent with the results of Cizginer et al. [19] , which confirmed that the elevated aminotransferase levels are correlated with the ablation volume.
Secondly, the heat produced by microwave antenna is delivered to liver parenchyma away from the ablation area and then harm the tissues. This damage usually happens when the tumor near a large vessel is ablated, as firstly reported by Jiang et al. [8] . Liu et al. [20] also found that thermal ablation for liver cancers adjacent to large vessels results in transiently damage of liver function. The results of this study also suggest that the larger portal vein the tumor is close to, the more seriously liver function is damaged. Besides, the loss of heat may increase the risk of inadequate tumor ablation [21] . In order to achieve complete necrosis of tumor, more liver parenchyma may be ablated. Hence, the incidence of liver damage will further increase.
Liver reserve function related factors have a great influence on the increase in Child-Pugh score instead of liver laboratory data. Patients with liver function of Child-Pugh classification B, high APRI, low level of PLT or large MELD scores have a high possibility of liver dysfunction. The effects of Child-Pugh score and PLT on liver function have been explored in previous studies. Li et al. [18] and Kuroda et al. [11] reported that patients with Child-Pugh scores larger than 8 are at the high risk of the aggravation of liver dysfunction after RFA. Lee et al. [10] demonstrated that thrombocytopenia is a critical parameter to predict the deterioration of liver function after RFA. These results were also confirmed by this study. However, none of the previous studies, to our best extent, mentioned the effects of APRI and MELD scores on liver dysfunction. APRI, an indicator of liver stiffness, can reflect the degree of liver cirrhosis directly [22, 23] . MELD scores is a system assessing the severity of chronic liver disease, eliminating the effects of two subjective variables, portosystemic encephalopathy and severity of ascites [24] . Both of APRI and MELD are related to liver dysfunction as depicted in this study.
This study has several limitations. Firstly, we did not take the influence of indocyanine green retention rate into account. Secondly, Chronic liver diseases may impact the results of this study, but we did not discuss the long-term change of hepatic function after the percutaneous tumor ablation. In future, a long-term casecontrol study may be helpful in accurately predicting the effects of MWA on liver function.
Conclusion
MWA is minimally invasive and with a relative low incidence of liver function damage in the treatment of HCC. Patients with tumors close to PV, large numbers of tumors and large ablation volumes may present a great fluctuation of liver enzymes and an aggravation of liver dysfunction. In addition, serious liver dysfunction is more likely to happen in patients with poor liver reserve function.
